methylone: Clinical Trials

7 trials of methylone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 recruiting, 1 unknown. 3 Phase 1, 3 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Unknown 1
Phase 23Completed 3
Phase 32Recruiting 2

Follow methylone: new trials by email Literature Review of methylone trials Research Report on methylone

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD
TSND-201, Placebo - Post Traumatic Stress Disorder
Phase 3RecruitingTranscend Therapeutics3002026-09-012026-09-23
An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSD (EMPOWER-1)
TSND-201, Placebo - Post Traumatic Stress Disorder
Phase 3RecruitingTranscend Therapeutics3002026-04-022026-09-17
An Evaluation of the Safety and Efficacy of Methylone for the Treatment of PTSD
Methylone - Post Traumatic Stress Disorder
Phase 2CompletedTranscend Therapeutics622024-04-042025-11-25
A Single, Ascending Dose Evaluation of the Safety, Pharmacokinetics of Methylone in Healthy Subjects
Methylone, Placebo - Post Traumatic Stress Disorder
Phase 1CompletedTranscend Therapeutics402024-03-202025-09-09
An Evaluation of the Long-term Efficacy and Safety of Methylone for the Treatment of PTSD
Methylone - Post Traumatic Stress Disorder
Phase 2CompletedTranscend Therapeutics442024-03-062025-11-25
A Study to Assess the Use of Methylone in the Treatment of PTSD
Methylone, Placebo - Post Traumatic Stress Disorder
Phase 1 / Phase 2CompletedTranscend Therapeutics792023-03-012026-04-15
Abuse Potential and Human Pharmacology of Methylone
Methylone, 3,4-methylenedioxymethamphetamine, Placebo - Substance Use, Healthy Subjects
Phase 1UnknownGermans Trias i Pujol Hospital172021-12-012022-08-08

Conditions studied

Stress Disorders, Post-Traumatic (6)  ·  Substance-Related Disorders (1)

Sponsors

Transcend Therapeutics (6)  ·  Germans Trias i Pujol Hospital (1)

Countries

United States (5)  ·  United Kingdom (3)  ·  Australia (2)  ·  Ireland (2)  ·  Spain (1)

Results publications

PMID 36873994, PMID 41706459